1. Purdue joining pharma’s top settlement list alongside Merck, GSK, and Pfizer — Biosimilars running into more roadblocks in the US — Big Pharma companies pay for exclusive access to UK genetic data — See more on our front page news

    TRY TWO WEEKS OF OUR EMAIL NEWS HEADLINES FOR FREE
    Dismiss Notice
  2. Think you have witnessed fraud?Ask a Whistleblower Attorney -- a chance to discuss whistleblower-related legal issues with practicing whistleblower attorneys.
    Dismiss Notice

New management

Discussion in 'Promius Pharma' started by anonymous, Jul 8, 2016 at 10:37 AM.

Tags: Add Tags
  1. anonymous

    anonymous Guest

    Being well-liked is great but not enough when there are other concerns. Not just with colleagues from India. We don't know the whole story - I'm sad, but don't want to second guess.
     
  2. anonymous

    anonymous Guest

    I heard from someone at his last company, the infusion job, he was immediately let go for ‘impropriety.’ Not sure what that means. He is missed though.
     
  3. anonymous

    anonymous Guest

    Could mean a lot of things, honestly, or that he rubbed people the wrong way, who knows? All seems "the norm" in this industry.
     
  4. anonymous

    anonymous Guest

    Agreed - there's usually more to the story than outsiders see. I liked the guy - I hope he's doing okay.
     
  5. anonymous

    anonymous Guest

    Same. I'm sure he's doing well. Haven't heard from him in a while, but he's smart, a good guy and won't be looking back, lol.
     
  6. anonymous

    anonymous Guest

    Run as fast as you can, no company goals being met, branded products are toast.from Princeton
     
  7. anonymous

    anonymous Guest

    A lot of decent people in a tough spot selling this junk. As far back as launch it was never managed properly. Nobody from the top down understood what they were doing, or what they were actually up against. They really missed the mark with this thinking whatever short sighted "innovations" would save it.

    "Look doc! Smallest needle in all the lands!"

    "Tell me about the cluster indications."

    "How's your sandwich?"
     
  8. anonymous

    anonymous Guest


    This is perfect
     
  9. anonymous

    anonymous Guest

    This might be cafepharma gold.
     
  10. anonymous

    anonymous Guest

    Or it could be the same old griping. Everything is a tough sell now. Zembrace is a great product - this from someone who uses it. It's a huge improvement over I used before. Sucks that insurance companies control so much of what docs can prescribe.
     
  11. anonymous

    anonymous Guest

    Yep.. and when this is your only product and so few making goals, the future seeems bleak.
    Nasal will have the same issues.. and now CGRP
     
  12. anonymous

    anonymous Guest

    This definitely seems like one person talking to his/herself
     
  13. anonymous

    anonymous Guest

    Yes it does.
     
  14. anonymous

    anonymous Guest

     
  15. anonymous

    anonymous Guest


    Agreed. Zembrace is a great product, it's the gold standard. Promius' molecular redesign of sumatriptan is changing hundreds of lives. Excited to sell this molecular redesigned nasal/eye drop/ huffing agent.
     
  16. anonymous

    anonymous Guest

    Molecular redesigned??!! Are you on dope? Do you even understand what that means? Zembrace has same molecule in similar injectable formulation as available in market albeit in concentrated form and a sexy device, again copied from preexisting autoinjector products, and that's not 'molecular redesign'. People like you who love talking loud without any real experience are curse to the company that did so well at one time. No doubt, DRL's stock is plummeting, profits are falling, and investors are fleeing.
     
  17. anonymous

    anonymous Guest

    I think he/she was being sarcastic? Or at least that's what I want to believe, but I have been wrong before. Are stocks and profits really tanking? I haven't paid attention, just seems to say so would also mean placing importance on this product...it just can't be that big of a thing either way.

    Also. Not a sexy device. Tried it, still can't get the red cap back and it was my last demo pen.
     
  18. anonymous

    anonymous Guest

    Perhaps the people that vent here about the horrible present and worse future will take their own advice and "run". It's hard not to wonder why anyone with such opinions of a company would stay. It's not that hard to find a new job. I was at a company with better products and stock prices, but I hated the management, so I left. Just saying.
     
  19. anonymous

    anonymous Guest

    Sometimes it's a choice between the big picture versus day to day life. I'm nervous about the big picture here, but I like my day to day job and colleagues.
     
  20. anonymous

    anonymous Guest